Cyclacel Pharmaceuticals Inc. (CYCC) Surges to 113th in Trading Volume with $78.6 Million Turnover

On July 15, 2025, Cyclacel Pharmaceuticals Inc. (CYCC) experienced a significant surge in trading volume, with a turnover of $78.6 million, marking a 1617.50% increase from the previous day. This substantial rise placed CYCC at the 113th position in terms of trading volume for the day. The stock price of CYCC soared by 272.51%, marking its third consecutive day of gains, with a cumulative increase of 232.35% over the past three days.

Cyclacel Pharmaceuticals Inc. (CYCC) saw a notable decline in its share price during Tuesday's after-hours trading session, dropping to $10.27. This decrease was part of a broader trend of price volatility experienced by the company's stock.

During Tuesday's regular trading session, Cyclacel Pharmaceuticals Inc. (CYCC) shares surged by 400.0%, reaching $16.55. This significant increase was driven by positive market sentiment and investor interest in the company's recent developments.

In the pre-market session on Tuesday, Cyclacel Pharmaceuticals Inc. (CYCC) shares rose by 41.04%, reaching $4.67. This increase followed a previous day's decline, indicating a rebound in investor confidence.

Cyclacel Pharmaceuticals Inc. (CYCC) was one of the top performers on the NASDAQ Composite, with its shares rising by 270.39% to $12.26. This substantial gain highlighted the company's strong market position and investor optimism.